Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation

NCT03100253 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

208

Enrollment

OTHER

Sponsor class

Stopped Slow recrutiment

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Tocilizumab
DRUG: Etanercept
DRUG: Infliximab
DRUG: Adalimumab
DRUG: Golimumab
DRUG: Certolizumab Pegol

Sponsor

Mario Negri Institute for Pharmacological Research